Aliases & Classifications for Fasciitis

MalaCards integrated aliases for Fasciitis:

Name: Fasciitis 12 54 44 15

Classifications:



External Ids:

Disease Ontology 12 DOID:9598
ICD9CM 34 729.4
MeSH 44 D005208
NCIt 50 C50559
SNOMED-CT 67 36948007
ICD10 32 M72.9
UMLS 70 C0015645

Summaries for Fasciitis

Disease Ontology : 12 A connective tissue disease characterized by inflammation located in the fascia.

MalaCards based summary : Fasciitis is related to pseudosarcomatous fibromatosis and proliferative fasciitis. An important gene associated with Fasciitis is ACTC1 (Actin Alpha Cardiac Muscle 1), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Epinephrine and Racepinephrine have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and bone marrow, and related phenotypes are cardiovascular system and cellular

Related Diseases for Fasciitis

Diseases related to Fasciitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1116)
# Related Disease Score Top Affiliating Genes
1 pseudosarcomatous fibromatosis 32.7 VIM USP6 MYH9 CD34 ACTC1
2 proliferative fasciitis 32.4 USP6 MYH9
3 necrotizing fasciitis 32.4 LTA IL6 IL2 IL1RN IL18 CXCL8
4 ischemic fasciitis 32.3 USP6 MYH9 CD34 ACTC1
5 intravascular fasciitis 32.3 USP6 MYH9 ESR1 CD34
6 toxic shock syndrome 31.5 TNF LTA IL6 IL2 IL1RN IFNG
7 hypereosinophilic syndrome 31.5 IL2 IFNG IFNA1 CXCL8
8 localized scleroderma 31.2 TNF IL6 IL2 CD34
9 erysipelas 31.0 TNF IL6 IL2
10 myositis 31.0 TNF IL6 IL2 IFNG IFNA1 CXCL8
11 soft tissue sarcoma 31.0 TP53 TNF IFNG
12 streptococcal toxic-shock syndrome 30.9 TNF LTA IL6 IL2 CXCL8
13 peritonitis 30.8 TNF IL6 IL18 CXCL8
14 chickenpox 30.8 TNF IL6 IL2 IFNG IFNA1 ACTC1
15 appendicitis 30.7 TNF IL6 IL2 IFNG CXCL8
16 fibrous histiocytoma 30.7 VIM CD34 ACTC1
17 septic arthritis 30.7 TNF IFNG CXCL8
18 graft-versus-host disease 30.6 TNF IL6 IL2 IFNG
19 carpal tunnel syndrome 30.6 IL6 IL2 ESR1
20 haemophilus influenzae 30.6 TNF CXCL8
21 pyelonephritis 30.6 TNF IL6 IFNG CXCL8
22 connective tissue disease 30.6 TP53 TNF IL6 IL2 IFNG CXCL8
23 mixed connective tissue disease 30.5 TNF IL6 IFNG
24 purpura 30.5 TNF IL6 IFNG
25 spindle cell sarcoma 30.5 VIM IL6 ETV6 CD34 ACTC1
26 osteomyelitis 30.5 TNF IL6 IL1RN IFNG CXCL8
27 pharyngitis 30.5 TNF IL6 CXCL8
28 perinatal necrotizing enterocolitis 30.5 TNF IL6 CXCL8
29 synovitis 30.5 TNF IL6 IL1RN IL18 CXCL8
30 pericarditis 30.4 TNF IL6 IFNG CXCL8
31 enterocolitis 30.4 TNF IL6 CXCL8 CD46
32 fibrosarcoma 30.4 VIM TP53 TNF ETV6 ACTC1
33 gout 30.4 TNF IL6 IL18 CXCL8
34 varicose veins 30.4 TNF IL6 CXCL8
35 sarcoma 30.4 VIM TP53 IL6 IFNA1 CXCL8 ACTC1
36 herpes zoster 30.4 TNF IL2 IFNG IFNA1
37 pleomorphic adenoma 30.4 VIM TP53 ACTC1
38 lyme disease 30.4 TNF IL6 IFNA1
39 exanthem 30.3 TNF IL6 IL2 IL18 IFNG IFNA1
40 pustulosis of palm and sole 30.3 TNF IL1RN CXCL8
41 cutaneous fibrous histiocytoma 30.3 VIM CD34 ACTC1
42 neutrophilic dermatosis, acute febrile 30.3 TNF IL1RN CXCL8
43 thyroiditis 30.3 TNF IL6 IL2 IFNG IFNA1
44 end stage renal disease 30.3 TNF MYH9 IL6 IL1RN CD46
45 dermatofibrosarcoma protuberans 30.3 VIM TP53 CD34 ACTC1
46 bacterial infectious disease 30.3 TNF IL6 IL1RN IL18 IFNG CXCL8
47 crohn's disease 30.3 TNF IL6 IL2 IL18 IFNG CXCL8
48 melioidosis 30.3 TNF IL6 IL18 IFNG
49 adult respiratory distress syndrome 30.3 TNF IL6 IL1RN CXCL8
50 alcoholic liver cirrhosis 30.3 TNF IL6 IL2 CXCL8

Graphical network of the top 20 diseases related to Fasciitis:



Diseases related to Fasciitis

Symptoms & Phenotypes for Fasciitis

MGI Mouse Phenotypes related to Fasciitis:

46 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.41 ACTC1 CD46 ESR1 ETV6 IFNG IL18
2 cellular MP:0005384 10.37 ACTC1 CD34 ESR1 ETV6 IFNG IL18
3 hematopoietic system MP:0005397 10.37 ACTC1 CD34 ESR1 ETV6 IFNG IL18
4 homeostasis/metabolism MP:0005376 10.35 ACTC1 CD34 ESR1 ETV6 IFNG IL18
5 immune system MP:0005387 10.27 CD34 ESR1 ETV6 IFNG IL18 IL1RN
6 digestive/alimentary MP:0005381 10.11 ESR1 ETV6 IFNG IL18 IL2 IL6
7 integument MP:0010771 10.09 CD34 ESR1 ETV6 IFNG IL18 IL1RN
8 liver/biliary system MP:0005370 10.01 ESR1 ETV6 IFNG IL2 IL6 LTA
9 muscle MP:0005369 9.97 ACTC1 ESR1 IFNG IL18 IL6 TNF
10 neoplasm MP:0002006 9.92 CD34 ESR1 ETV6 IFNG IL2 IL6
11 no phenotypic analysis MP:0003012 9.86 ESR1 ETV6 IFNG IL2 MYH9 TNF
12 reproductive system MP:0005389 9.85 CD46 ESR1 IFNG IL1RN IL2 IL6
13 respiratory system MP:0005388 9.56 ESR1 IFNG IL2 IL6 LTA TNF
14 vision/eye MP:0005391 9.32 CD46 IFNG IL18 IL2 IL6 LTA

Drugs & Therapeutics for Fasciitis

Drugs for Fasciitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 106)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
2
Racepinephrine Approved Phase 4 329-65-7 838
3
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
4
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
5
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
6
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
7
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
8
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
9
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
10
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
11
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
12 Epinephryl borate Phase 4
13 Pharmaceutical Solutions Phase 4
14 glucocorticoids Phase 4
15 Hormone Antagonists Phase 4
16 Hormones Phase 4
17 Anti-Inflammatory Agents Phase 4
18 Methylprednisolone Acetate Phase 4
19 incobotulinumtoxinA Phase 4
20 Gastrointestinal Agents Phase 4
21 Antiemetics Phase 4
22 Antineoplastic Agents, Hormonal Phase 4
23 Neuroprotective Agents Phase 4
24 Protective Agents Phase 4
25
Povidone-iodine Approved Phase 2, Phase 3 25655-41-8
26
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 5743
27
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3
28
Povidone Approved Phase 2, Phase 3 9003-39-8 131751496
29
Iodine Approved, Investigational Phase 2, Phase 3 7553-56-2 807
30
Cadexomer iodine Experimental Phase 2, Phase 3 94820-09-4
31
rituximab Approved Phase 2 174722-31-7 10201696
32 Antirheumatic Agents Phase 2
33 Antineoplastic Agents, Immunological Phase 2
34 Immunoglobulins Phase 2
35 Antibodies Phase 2
36 Immunologic Factors Phase 2
37 gamma-Globulins Phase 2
38 Immunoglobulin G Phase 2
39 Immunoglobulins, Intravenous Phase 2
40 Rho(D) Immune Globulin Phase 2
41
Betamethasone Approved, Vet_approved Phase 1 378-44-9 9782
42
Ropivacaine Approved Phase 1 84057-95-4 71273 175805
43
Carbon monoxide Approved, Investigational Phase 1 630-08-0 281
44 Anti-Asthmatic Agents Phase 1
45 Respiratory System Agents Phase 1
46 Betamethasone Valerate Phase 1 2152-44-5
47 Betamethasone benzoate Phase 1
48 Betamethasone sodium phosphate Phase 1
49 Betamethasone-17,21-dipropionate Phase 1
50 Betamethasone acetate Phase 1

Interventional clinical trials:

(show top 50) (show all 141)
# Name Status NCT ID Phase Drugs
1 A Post-marketing Surveillance to Evaluate the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Unknown status NCT02539082 Phase 4 normal saline
2 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
3 Plantar Fasciitis: Pain Relief and Improvement of Foot Function With Prolotherapy Unknown status NCT01326351 Phase 4
4 Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study Completed NCT00222911 Phase 4
5 Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study Completed NCT00189592 Phase 4
6 Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study Completed NCT01678001 Phase 4 Xeomin
7 Use of PRP to Treat Plantar Fasciitis, Blinded and Randomized as a Multi Center Study Completed NCT00758641 Phase 4 Corticosteroid Injection
8 Clinical Effectiveness of Quiropodiatry and Orthesis on Heel and Plantar Pain: Randomized Control Trial Completed NCT00888394 Phase 4
9 Optimal Treatment of Plantar Fasciitis: A Randomized Clinical Trial Using Physical Training, Glucocorticoid Injections or a Combination Thereof. Completed NCT01994759 Phase 4 Glucocorticosteroid injection
10 Chronic Plantar Fasciitis Treated With Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? A Randomized Controlled Clinical Trial. Completed NCT02608723 Phase 4
11 Randomized Clinical Trial Comparing Conventional Conservative Treatment for Plantar Fasciopathia With Endoscopic Surgery With Fascial Release. Completed NCT02448316 Phase 4 methylprednisolon;lidokaine
12 Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy Terminated NCT01588730 Phase 4
13 "Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis" Withdrawn NCT00420875 Phase 4
14 The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Unknown status NCT01786057 Phase 2, Phase 3
15 PSU Heel Cushion for Treatment of Plantar Fasciitis:A Randomized Controlled Trial Unknown status NCT01017406 Phase 3
16 Continuous Low Energy Pulsed Radio Frequency Electromagnetic Field Therapy for the Treatment of Plantar Fasciopathy Completed NCT01431066 Phase 3
17 Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis Completed NCT00447876 Phase 2, Phase 3 Placebo
18 A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis Completed NCT02427191 Phase 2, Phase 3 Saline Injection
19 A Clinical Trial of a Multi-Element Exercise Program for Plantar Fasciopathy in Workers Required to Stand for Prolonged Periods of Time Completed NCT01297686 Phase 2, Phase 3 Dexamethasone
20 Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections) Completed NCT02469857 Phase 3 AB103 0.5 mg/kg
21 Placebo Controlled Study to Investigate the Effectiveness and Safety of Extracorporeal Shock Wave Therapy in Unsuccessful Conservatively Treated Subject Suffering From Painful Heel Syndrome Completed NCT00720694 Phase 3
22 A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis Active, not recruiting NCT03414268 Phase 3 Saline Injection
23 Steroid Injections vs. Platelet Rich Plasma Injections in Patients With Plantar Fasciitis: A Comparison of Clinical and Ultrasound Findings Withdrawn NCT01957631 Phase 2, Phase 3 Corticosteroid injection (Bupivacaine and Depo Medrol)
24 A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy Unknown status NCT00936546 Phase 2 Rituximab
25 A Phase II, Prospective, Randomized, Double-Blind, Multi-center, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Completed NCT03825315 Phase 2
26 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Completed NCT03137407 Phase 2
27 Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Completed NCT02111161 Phase 2 IVIG (Privigen);Saline 0.9%
28 Treatment of Osteoporosis With Unfocused Extracorporeal Shock Wave Therapy: Pilot Study Completed NCT02630381 Phase 2
29 A Phase II Clinical Trial Evaluating the Safety and Effect of abobotulinumtoxinA Injection in the Gastrocnemius Muscle to Improve Equinus and Associated Plantar Fasciitis Pain Recruiting NCT03978234 Phase 2 AbobotulinumtoxinA 300 UNT
30 A Single-Arm, Open-Label, Phase I/II Study of Glasdegib for Sclerotic Chronic Graft-Vs-Host Disease Recruiting NCT04111497 Phase 1, Phase 2 Glasdegib
31 A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Terminated NCT02973269 Phase 2
32 Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis. Completed NCT03054610 Phase 1 Betamethason Sodium Phosphate;Ropivacaine;Botulinum Toxins, Type A
33 Manual Therapy Informed by the Fascia Distortion Model for Plantar Heel Pain: Results of a Single-arm Prospective Effectiveness Study Completed NCT04571073 Phase 1
34 A Prospective, Non-Randomized, Open-Label Study on the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children Completed NCT00670891 Phase 1
35 Mepolizumab for the Treatment of Eosinophilic Fasciitis; An Open-Label, Single-Arm, Exploration Study Not yet recruiting NCT04305678 Phase 1 Mepolizumab
36 Shulman Fasciitis Prevalence Study in Alsace Unknown status NCT02829112
37 Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment: A Randomized Controlled Trial. Unknown status NCT01882894
38 Joints Mobilization Versus Myofascial Release on Diabetic Patients With Painful Heel Unknown status NCT03851848
39 Factors Associated With Complications of Cervical Necrotizing Fasciitis Unknown status NCT02847234
40 The Effectiveness of Platelet Rich Plasma in Treatment of Chronic Planter Fasciitis Unknown status NCT03938896
41 Effectiveness of Photobiomodulation Compared to Usual Care for Plantar Fasciitis Unknown status NCT03015116
42 Severe Soft Tissue Infections: Perspectives of Patients and Significant Others Unknown status NCT02169128
43 The Investigation of Biomechanical Mechanism of Different Foot Structures on Plantar Fasciitis and the Evaluation of Efficacy on Therapeutic Footwear Unknown status NCT01363375
44 A Randomized Double-Blind Clinical Trial to Investigate the Use of Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis Unknown status NCT01614223 Corticosteroid (celestone) injection
45 Integrated 3D Surface Scanning System Combined With Soft Tissue and Skeleton Information: Customized Shoe-padding Orthotics for Plantar Fasciitis Unknown status NCT03226288
46 Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis Unknown status NCT01981226
47 A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy With Platelet Rich Plasma Versus Extracorporeal Shock Wave Therapy in a High Demand Cohort With Resistant Plantar Fasciitis Unknown status NCT02668510 Normal saline
48 Genetic Susceptibility to Invasive Streptococcal Disease Unknown status NCT01911572
49 Effect of Plantar Fasciitis Foot Insole Unknown status NCT01549678
50 Effectiveness of Extracorporeal Shockwave Therapy on the Patients With Nocturnal Leg Cramps - Possible Related to Myofascial Trigger Point in the Gastrocnemius Muscle Unknown status NCT03864770

Search NIH Clinical Center for Fasciitis

Cochrane evidence based reviews: fasciitis

Genetic Tests for Fasciitis

Anatomical Context for Fasciitis

MalaCards organs/tissues related to Fasciitis:

40
Skin, Breast, Bone Marrow, Neutrophil, Colon, Myeloid, Spinal Cord

Publications for Fasciitis

Articles related to Fasciitis:

(show top 50) (show all 7981)
# Title Authors PMID Year
1
Cranial fasciitis of childhood: a case report and review of literature. 54 61
18190448 2008
2
Cranial and extracranial fasciitis of childhood: a clinicopathologic and immunohistochemical study. 61 54
9923933 1999
3
A thigh urinary fistula following radical prostatectomy and external beam radiation therapy for prostate cancer: a case report. 61
33511034 2021
4
Platelet-Rich Plasma Versus Corticosteroids for the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis. 61
32822236 2021
5
Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature. 61
33787639 2021
6
Clinicopathological and molecular characterisation of USP6-rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone-forming capacity. 61
33000481 2021
7
Biologics in the Treatment of Plantar Fasciitis. 61
33745655 2021
8
Plantar Fasciitis/Fasciosis. 61
33745651 2021
9
Necroziting fasciitis in right leg secondary to a presacral abscess related to colorectal anastomosis failure. 61
32703655 2021
10
Atypical Presentation of Severe Fungal Necrotizing Fasciitis in a Patient with X-Linked Agammaglobulinemia. 61
33713249 2021
11
Healing of Chronic Wounds by Copper Oxide-Impregnated Wound Dressings-Case Series. 61
33809898 2021
12
A Narrative Review Evaluating Extracorporeal Shockwave Therapy as a Potential Regenerative Treatment for Musculoskeletal Conditions in Military Personnel. 61
33770175 2021
13
Exercise therapy for the treatment of tendinopathies: a scoping review protocol. 61
33741838 2021
14
Foot and Ankle Injections in Athletes. 61
33759634 2021
15
The combined score of quick SOFA and the charlson comorbidity index could be a poor prognostic indicator for in-hospital mortality among patients with necrotizing fasciitis. 61
33678549 2021
16
Intravascular Fasciitis of the Femoral Vein Mimicking Thrombosis and Sarcoma. 61
33223286 2021
17
Plantar vein thrombosis masquerading as plantar fasciitis: A case report. 61
32842848 2021
18
Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. 61
33768893 2021
19
Platelet-Rich Plasma for Chronic Plantar Fasciitis: as with any other treatment, a comprehensive protocol is necessary. 61
33461924 2021
20
Platelet-Rich Plasma vs. Corticosteroids for Refractory Plantar Fasciitis. 61
33630557 2021
21
A case of cervical fasciitis complicated by mediastinitis and pre-peritoneal abscess: the role of video-assisted thoracoscopic surgery. 61
33642717 2021
22
Intravascular Fasciitis in the Femoral Vein with Hypermetabolic Signals Mimicking a Sarcoma: The Role of Preoperative Imaging Studies with Review of Literature. 61
33775935 2021
23
Necrotizing Fasciitis Shock Syndrome by Group A Hemolytic Streptococcus: Report of 6 Cases and Clinical Management. 61
33739051 2021
24
Necrotizing fasciitis of the upper extremity: a retrospective analysis of 19 cases. 61
33812083 2021
25
Necrotising fasciitis of the thoracic wall: a rare case with favourable outcome. 61
33674292 2021
26
Aeromonas sobria necrotizing fasciitis complicating neonatal sclerosing cholangitis. 61
33810916 2021
27
Ubiquitin-specific Peptidase 6 (USP6)-associated Fibroblastic/Myofibroblastic Tumors: Evolving Concepts. 61
33608306 2021
28
Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report. 61
33722291 2021
29
Successful application of focused extracorporeal shockwave therapy for plantar fasciitis in patients suffering from metastatic breast cancer. 61
33745042 2021
30
The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast. 61
33730427 2021
31
GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast. 61
33770555 2021
32
First application of focused low-energy extracorporeal shockwave therapy in a patient with severe hemophilia A and plantar fasciitis. 61
32533438 2021
33
The enigmatic fascia: eosinophilic fasciitis. 61
33783170 2021
34
Ultrasound in the diagnosis and monitoring of eosinophilic fasciitis. 61
33099646 2021
35
A clue for eosinophilic fasciitis: groove sign. 61
32929499 2021
36
Assessment of Outcomes After Limberg Flap Reconstruction for Scrotal Defects in Patients With Fournier's Gangrene. 61
33793411 2021
37
Treating Heel Pain in Adults: A Randomized Controlled Trial of Hard vs Modified Soft Custom Orthotics and Heel Pads. 61
33217374 2021
38
On the morphological relations of the Achilles tendon and plantar fascia via the calcaneus: a cadaveric study. 61
33727610 2021
39
Early and aggressive surgical debridement and negative pressure wound therapy to treat necrotizing fasciitis in three dogs. 61
33724500 2021
40
Negative pressure wound therapy with instillation and dwell time in the wound management of necrotizing fasciitis. 61
33707160 2021
41
Post-partum necrotizing fasciitis of the breast: a case study. 61
33755296 2021
42
Necrotizing fasciitis secondary to lake water inoculation with Aeromonas sobria: A case report. 61
33725868 2021
43
Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar Fasciitis. 61
33030035 2021
44
Cervical necrotising fasciitis presenting with mild symptoms. 61
33664046 2021
45
Is Dry Needling Effective for the Management of Plantar Heel Pain or Plantar Fasciitis? An Updated Systematic Review and Meta-analysis. 61
33760098 2021
46
Cross-Cultural Adaptation and Validation of the Pain Scale for Plantar Fasciitis to Spanish. 61
33229244 2021
47
Correction to: Palmar fasciitis and polyarthritis: an uncommon but remarkable paraneoplastic syndrome. 61
33555461 2021
48
Comparison of Effectiveness of Density and Number of Sessions of Extracorporeal Shock Wave Therapy in Plantar Fasciitis Patients: A Double-Blind, Randomized-Controlled Study. 61
33191061 2021
49
Association of Ankle Dorsiflexion With Plantar Fasciitis. 61
33771432 2021
50
High-throughput 16S rDNA sequencing assisting in the detection of bacterial pathogen candidates: a fatal case of necrotizing fasciitis in a child. 61
32895762 2021

Variations for Fasciitis

Expression for Fasciitis

Search GEO for disease gene expression data for Fasciitis.

Pathways for Fasciitis

Pathways related to Fasciitis according to GeneCards Suite gene sharing:

(show top 50) (show all 65)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.04 VIM TP53 TNF MYH9 LTA IL6
2
Show member pathways
13.87 VIM TP53 TNF MYH9 LTA IL6
3
Show member pathways
13.73 TP53 TNF LTA IL6 IL2 IL1RN
4
Show member pathways
13.58 TP53 TNF LTA IL6 IL2 IL18
5
Show member pathways
13.34 TNF MYH9 LTA IL6 IL2 IL18
6
Show member pathways
13.31 VIM TP53 TNF LTA IL6 IL2
7
Show member pathways
13.24 TP53 TNF IL6 IL2 IL18 IFNG
8 12.89 TP53 IL6 IL2 IFNG IFNA1 ESR1
9 12.86 TP53 TNF LTA IL6 IFNG IFNA1
10
Show member pathways
12.85 VIM TNF LTA IL6 IL2 IFNG
11
Show member pathways
12.78 TNF MYH9 IL6 IL18 CXCL8
12
Show member pathways
12.78 TNF IL6 IL1RN IL18 IFNA1 CXCL8
13
Show member pathways
12.64 VIM TNF IL6 IL2 IFNG
14
Show member pathways
12.64 TP53 TNF IL6 IL2 IL18 IFNG
15
Show member pathways
12.63 TNF IL6 IL2 IL18 IFNG
16 12.59 TNF IL2 IL1RN IFNG IFNA1 CD46
17 12.4 TP53 TNF LTA IL6 IL2
18
Show member pathways
12.4 TNF LTA IL6 IL2 IL18 CXCL8
19
Show member pathways
12.39 TP53 TNF IL6 IL2 IFNG
20
Show member pathways
12.37 TNF IL6 IFNG CXCL8
21
Show member pathways
12.37 TP53 TNF IL6 IFNG CXCL8
22 12.31 TP53 IL6 ETV6 CXCL8
23 12.3 TNF IL6 IL18 IFNA1 CXCL8
24 12.29 TNF IL6 IL18 IFNG IFNA1
25 12.23 TP53 TNF IL6 IFNG
26
Show member pathways
12.23 TNF IL6 IFNG CXCL8
27 12.22 TNF IL6 IL1RN CXCL8
28 12.15 TNF IL6 IL2 IL18 CXCL8
29 12.06 TNF IL6 IL2 IFNG CD34
30
Show member pathways
12.03 VIM TP53 TNF IL6 IL2 IL18
31 12 TP53 IL6 IFNG CXCL8
32 11.98 TNF IL6 IFNG CXCL8
33 11.93 TNF IL6 IL18 IFNG CXCL8
34 11.9 VIM TP53 TNF IL6 IL18 CXCL8
35 11.86 TP53 IL6 IL2 IFNG CXCL8
36
Show member pathways
11.83 TNF IL2 IFNG CXCL8
37
Show member pathways
11.82 TP53 TNF LTA IL6 IL2 IL18
38 11.79 TNF IL6 CXCL8
39 11.79 TNF IL6 IL2 IFNG CD34
40 11.78 VIM TP53 TNF IL6 IL2 IFNG
41 11.73 IL2 IFNG ESR1
42 11.73 TNF LTA IL6
43 11.7 TNF IL6 CXCL8
44 11.7 TNF LTA IL2 IL18 IFNG CD34
45
Show member pathways
11.69 TNF IL6 IL2 IFNG CXCL8
46
Show member pathways
11.68 TNF IL2 IFNG
47 11.68 TNF IL6 IL18 CXCL8
48 11.64 IL6 IFNG CXCL8
49
Show member pathways
11.61 TNF LTA IL6 IL2 IL18 IFNG
50 11.6 TP53 IL6 CXCL8

GO Terms for Fasciitis

Cellular components related to Fasciitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 TNF LTA IL6 IL2 IL1RN IL18
2 extracellular space GO:0005615 9.32 TNF LTA IL6 IL2 IL1RN IL18

Biological processes related to Fasciitis according to GeneCards Suite gene sharing:

(show all 34)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 10.18 TP53 TNF IL6 IL2 IL18 ETV6
2 inflammatory response GO:0006954 10.01 TNF IL6 IL1RN IL18 CXCL8
3 negative regulation of gene expression GO:0010629 9.91 TP53 TNF IFNG ESR1 CXCL8 CD46
4 cellular response to lipopolysaccharide GO:0071222 9.88 VIM TNF IL6 CXCL8
5 immune response GO:0006955 9.86 TNF LTA IL6 IL2 IL1RN IL18
6 regulation of insulin secretion GO:0050796 9.83 TNF IL6 IFNG
7 response to glucocorticoid GO:0051384 9.82 TNF IL6 IL1RN
8 positive regulation of T cell proliferation GO:0042102 9.82 IL6 IL2 CD46
9 positive regulation of smooth muscle cell proliferation GO:0048661 9.81 TNF IL6 IL18
10 positive regulation of inflammatory response GO:0050729 9.81 TNF IL2 IL18 IFNG
11 positive regulation of interleukin-1 beta production GO:0032731 9.78 TNF IL6 IFNG
12 positive regulation of interferon-gamma production GO:0032729 9.76 TNF LTA IL2 IL18
13 positive regulation of chemokine production GO:0032722 9.75 TNF IL6 IFNG
14 positive regulation of interleukin-10 production GO:0032733 9.74 IL6 CD46 CD34
15 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.72 TNF IL6 IL2 IL18 IFNG
16 positive regulation of glial cell proliferation GO:0060252 9.67 TNF LTA IL6
17 positive regulation of transforming growth factor beta production GO:0071636 9.66 CD46 CD34
18 response to salt stress GO:0009651 9.66 TP53 TNF
19 negative regulation of lipid storage GO:0010888 9.65 TNF IL6
20 positive regulation of interleukin-17 production GO:0032740 9.65 IL6 IL2 IL18
21 positive regulation of gene expression GO:0010628 9.65 VIM TP53 TNF IL6 IL18 IFNG
22 negative regulation of interleukin-1-mediated signaling pathway GO:2000660 9.63 IL6 IL1RN
23 circadian behavior GO:0048512 9.62 USP2 TP53
24 vascular endothelial growth factor production GO:0010573 9.62 TNF IL6
25 positive regulation of neuroinflammatory response GO:0150078 9.61 TNF IL6 IL18
26 positive regulation of tissue remodeling GO:0034105 9.6 IL2 IL18
27 positive regulation of humoral immune response mediated by circulating immunoglobulin GO:0002925 9.59 TNF LTA
28 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 9.58 TP53 TNF ESR1
29 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.56 TNF IFNG
30 positive regulation of vitamin D biosynthetic process GO:0060557 9.55 TNF IFNG
31 humoral immune response GO:0006959 9.55 TNF LTA IL6 IFNG IFNA1
32 positive regulation of nitrogen compound metabolic process GO:0051173 9.54 TNF IFNG
33 positive regulation of chronic inflammatory response to antigenic stimulus GO:0002876 9.52 TNF LTA
34 cytokine-mediated signaling pathway GO:0019221 9.28 VIM TP53 TNF IL6 IL2 IL1RN

Molecular functions related to Fasciitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.28 TNF LTA IL6 IL2 IL1RN IL18

Sources for Fasciitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....